CN105688288A - Collagen based composite dental restoration membrane material and preparation method thereof - Google Patents
Collagen based composite dental restoration membrane material and preparation method thereof Download PDFInfo
- Publication number
- CN105688288A CN105688288A CN201610130834.3A CN201610130834A CN105688288A CN 105688288 A CN105688288 A CN 105688288A CN 201610130834 A CN201610130834 A CN 201610130834A CN 105688288 A CN105688288 A CN 105688288A
- Authority
- CN
- China
- Prior art keywords
- collagen
- membrane material
- preparation
- solution
- carboxymethyl chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 76
- 108010035532 Collagen Proteins 0.000 title claims abstract description 76
- 229920001436 collagen Polymers 0.000 title claims abstract description 76
- 239000000463 material Substances 0.000 title claims abstract description 61
- 239000012528 membrane Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000002131 composite material Substances 0.000 title abstract description 26
- 229920001661 Chitosan Polymers 0.000 claims abstract description 32
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims abstract description 30
- 230000033558 biomineral tissue development Effects 0.000 claims abstract description 18
- 230000003592 biomimetic effect Effects 0.000 claims abstract description 15
- 238000004132 cross linking Methods 0.000 claims abstract description 10
- 238000001338 self-assembly Methods 0.000 claims abstract description 10
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 8
- 238000004108 freeze drying Methods 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 3
- 230000008439 repair process Effects 0.000 claims description 23
- 239000008367 deionised water Substances 0.000 claims description 20
- 229910021641 deionized water Inorganic materials 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 239000007800 oxidant agent Substances 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 6
- 230000001590 oxidative effect Effects 0.000 claims description 6
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical class CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 229910001220 stainless steel Inorganic materials 0.000 claims description 5
- 239000010935 stainless steel Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000003431 cross linking reagent Substances 0.000 claims description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 4
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 3
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims description 3
- 206010070834 Sensitisation Diseases 0.000 claims description 2
- 230000003013 cytotoxicity Effects 0.000 claims description 2
- 231100000135 cytotoxicity Toxicity 0.000 claims description 2
- 230000036512 infertility Effects 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 230000008313 sensitization Effects 0.000 claims description 2
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 claims description 2
- 229910001488 sodium perchlorate Inorganic materials 0.000 claims description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 229960000935 dehydrated alcohol Drugs 0.000 claims 1
- 230000012447 hatching Effects 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims 1
- 229920002414 procyanidin Polymers 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 102000012422 Collagen Type I Human genes 0.000 abstract description 25
- 108010022452 Collagen Type I Proteins 0.000 abstract description 25
- 238000000034 method Methods 0.000 abstract description 13
- 230000008569 process Effects 0.000 abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 5
- 230000015556 catabolic process Effects 0.000 abstract description 4
- 238000006731 degradation reaction Methods 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000004584 polyacrylic acid Substances 0.000 abstract 2
- 239000012890 simulated body fluid Substances 0.000 abstract 2
- 230000002308 calcification Effects 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 28
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 6
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical group [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 description 3
- 229940059329 chondroitin sulfate Drugs 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003402 anti-promotion Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005234 chemical deposition Methods 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000013384 organic framework Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L31/129—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/028—Other inorganic materials not covered by A61L31/022 - A61L31/026
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域 technical field
本发明涉及胶原基复合口腔修复膜材料及其制备方法,属于口腔医用材料领域。 The invention relates to a collagen-based composite oral repair membrane material and a preparation method thereof, belonging to the field of oral medical materials.
背景技术 Background technique
口腔修复膜是通过在口腔软组织与骨缺损之间建立一层生物屏障,来创造一个良好的再生修复空间,它可以通过选择性地阻挡迁移速度较快的细胞进入骨缺损区,同时又促进诱导口腔伤口愈合。显然,良好的口腔修复膜应具有机械屏障作用、血管化作用、参与代谢过程和诱导作用等。 The oral repair membrane creates a good regenerative repair space by establishing a biological barrier between the oral soft tissue and the bone defect. Oral wound healing. Obviously, a good oral repair membrane should have mechanical barrier effect, vascularization effect, participation in metabolic process and induction effect, etc.
胶原是一种具有生物功能的结构蛋白质,占人体蛋白质总量的1/3,是构成皮肤、软骨、韧带、肌腱等结缔组织或器官的主要成分。天然的I型胶原具有较好的力学性能和重要的生物学性质,具有可生物降解性和良好的生物相容性,还非常有利于组织培养中的细胞黏附、增殖和分化等功能,其在生物医学领域有着广泛的应用价值。虽然I型胶原有如此多的优点,但仍存在单纯胶原凝胶力学强度较差,具有抗原性等,限制了它的应用,因此,研究人员寻找各种方法来提高其性能以弥补其不足。羧甲基壳聚糖是一种水溶性壳聚糖衍生物,羧甲基基团的存在有利于后期Ca2+离子的沉积。羧甲基壳聚糖也继承了壳聚糖的诸多优点如抗菌抑菌性、抗肿瘤、促进伤口愈合等性能。氧化后的羧甲基壳聚糖引入了醛基,可与胶原上的氨基发生席夫碱反应,原位交联,具有较高的反应活性,可提高胶原基复合膜材料的力学性能、可降解吸收性等。 Collagen is a structural protein with biological functions, accounting for 1/3 of the total protein in the human body, and is the main component of connective tissues or organs such as skin, cartilage, ligaments, and tendons. Natural type I collagen has good mechanical properties and important biological properties, biodegradability and good biocompatibility, and is also very beneficial to cell adhesion, proliferation and differentiation in tissue culture. Biomedical field has a wide range of application value. Although type I collagen has so many advantages, it still has poor mechanical strength and antigenicity of pure collagen gel, which limits its application. Therefore, researchers are looking for various methods to improve its performance to make up for its shortcomings. Carboxymethyl chitosan is a water-soluble chitosan derivative, and the presence of carboxymethyl groups is beneficial to the deposition of Ca 2+ ions in the later stage. Carboxymethyl chitosan also inherits many advantages of chitosan, such as antibacterial and antibacterial properties, anti-tumor properties, and promotion of wound healing. The oxidized carboxymethyl chitosan introduces aldehyde groups, which can undergo Schiff base reaction with amino groups on collagen, in situ cross-linking, and has high reactivity, which can improve the mechanical properties of collagen-based composite membrane materials, and can Degradation absorbency etc.
自组装性是胶原的一个重要性质。人体天然牙的基本有机框架是由Ⅰ型胶原分子构成的,其形成过程主要有:胶原基质的合成、细胞外组装以及生物矿化。在形成过程中,Ⅰ型胶原分子本身先进行了一系列多级有序的自组装,其分级结构为:原胶原分子→胶原微纤维→胶原纤维→矿化基质的三维网状结构。胶原纤维提供了后期羟基磷灰石的沉积基板,在胶原纤维孔区的非胶原成分提供了羟基磷灰石形核的位点并排列了形成取向,可起到桥接羟基磷灰石与胶原的作用。 Self-assembly is an important property of collagen. The basic organic framework of human natural teeth is composed of type I collagen molecules, and its formation process mainly includes: synthesis of collagen matrix, extracellular assembly and biomineralization. During the formation process, the type Ⅰ collagen molecule itself undergoes a series of multi-level and orderly self-assembly, and its hierarchical structure is: three-dimensional network structure of procollagen molecule→collagen microfibril→collagen fiber→mineralized matrix. Collagen fibers provide the substrate for the deposition of hydroxyapatite in the later stage, and the non-collagen components in the pore area of the collagen fibers provide sites for the nucleation of hydroxyapatite and arrange the formation orientation, which can act as a bridge between hydroxyapatite and collagen effect.
目前,口腔修复膜材料主要是一些材料的简单复合。例如,专利CN104922732A公开了一种口腔生物膜制备方法,将胶原与硫酸软骨素配置成浆液,真空冷冻干燥压制成胶原复合薄膜,再向两层胶原复合薄膜中喷涂胶原—硫酸软骨素浆液,真空冷冻干燥,高温真空交联、灭菌处理后即得胶原—硫酸软骨素复合口腔生物膜。专利CN101081314B公开了一种复合羟基磷灰石的胶原/壳聚糖支架的制备方法,其首先制备了交联的胶原/壳聚糖支架,接着采用化学沉积的方法将羟基磷灰石复合到支架上,最后利用矿化的方法获得活性的复合骨支架。 At present, oral restoration membrane materials are mainly simple composites of some materials. For example, the patent CN104922732A discloses a preparation method of oral biofilm. Collagen and chondroitin sulfate are configured into a slurry, vacuum freeze-dried and pressed into a collagen composite film, and then the collagen-chondroitin sulfate slurry is sprayed into the two-layer collagen composite film. The collagen-chondroitin sulfate composite oral biofilm is obtained after freeze-drying, high-temperature vacuum cross-linking and sterilization. Patent CN101081314B discloses a preparation method of a collagen/chitosan scaffold composited with hydroxyapatite, which first prepares a cross-linked collagen/chitosan scaffold, and then uses chemical deposition to compound hydroxyapatite to the scaffold Finally, the active composite bone scaffold was obtained by mineralization.
上述方法中,存在以下不足:(1)大部分胶原原材料是胶原分子或胶原的水解产物,与人体天然牙中的胶原纤维成分不同或已失去胶原本身具有生物活性的三股螺旋结构;(2)复合的材料与胶原不能形成大量有效交联,影响修复膜材料的力学性能与可降解吸收性等;(3)复合的材料本身不具备优良的性能,不能赋予修复膜材料以新的更为优异的性能;(4)仿生矿化过程简单,未加入其他元素进行矿化的调控。 In the above method, there are the following deficiencies: (1) Most of the collagen raw materials are collagen molecules or hydrolyzed products of collagen, which are different from the collagen fiber components in human natural teeth or have lost the biologically active triple helical structure of collagen itself; (2) The composite material and collagen cannot form a large amount of effective cross-linking, which affects the mechanical properties and degradable absorption of the repair membrane material; (3) The composite material itself does not have excellent performance, and cannot endow the repair membrane material with new and more excellent (4) The biomimetic mineralization process is simple, and no other elements are added to regulate the mineralization.
发明内容 Contents of the invention
本发明的目的是为口腔医用材料领域提供一种生物相容性良好的胶原基复合材料,该膜材料在制备方法上模拟人体天然牙的形成过程,同时通过复合还具有良好的力学性能、抗菌抑菌性以及适宜可控的降解吸收性,原料价廉易得,具有良好的应用前景。 The purpose of the present invention is to provide a collagen-based composite material with good biocompatibility for the field of oral medical materials. Bacteriostasis and suitable and controllable degradation and absorption, raw materials are cheap and easy to obtain, and have good application prospects.
本发明的目的是由以下技术措施来实现的: The purpose of the present invention is achieved by the following technical measures:
(1)氧化羧甲基壳聚糖的制备:将10~100重量份的去离子水加入到不锈钢反应釜中,然后将羧甲基壳聚糖与氧化剂以1:0.1~2.5的质量比加入,并使之溶解完全。接着,在0~20℃下避光搅拌反应10~50h,再加入5~50重量份的氯化钠与50~1000体积份的无水乙醇,静置,将底部液体以10000~15000r/min离心10~30min,最后在去离子水中透析3~5d,冷冻干燥即得氧化羧甲基壳聚糖; (1) Preparation of oxidized carboxymethyl chitosan: Add 10-100 parts by weight of deionized water into a stainless steel reactor, and then add carboxymethyl chitosan and oxidant at a mass ratio of 1:0.1-2.5 , and dissolve it completely. Next, stir and react in the dark at 0~20°C for 10~50h, then add 5~50 parts by weight of sodium chloride and 50~1000 parts by volume of absolute ethanol, let it stand, and mix the bottom liquid at 10000~15000r/min Centrifuge for 10-30 minutes, finally dialyze in deionized water for 3-5 days, and freeze-dry to obtain oxidized carboxymethyl chitosan;
(2)热驱动Ⅰ型胶原自组装:将Ⅰ型胶原溶解在缓冲液中,使得Ⅰ型胶原浓度为1~5mg/ml。将搅拌均匀的Ⅰ型胶原溶液在37℃下孵化10~24h后,加入氧化羧甲基壳聚糖搅拌3~6h,再在37℃下继续孵化10~24h,最后将产物冷冻干燥备用; (2) Heat-driven type I collagen self-assembly: Dissolve type I collagen in buffer solution so that the concentration of type I collagen is 1-5 mg/ml. After incubating the well-stirred type I collagen solution at 37°C for 10-24 hours, add oxidized carboxymethyl chitosan and stir for 3-6 hours, then continue to incubate at 37°C for 10-24 hours, and finally freeze-dry the product for later use;
(3)胶原基材料的预处理:将步骤(2)所得胶原基材料浸入交联剂溶液中交联0.5~12h,然后将材料在37℃下浸没于0.1~0.5mol/L的Ca(NO3)2溶液中4~24h,每12h更换一次Ca(NO3)2溶液,取出后用去离子水轻轻冲洗3次; (3) Pretreatment of collagen-based materials: immerse the collagen-based materials obtained in step (2) in a cross-linking agent solution for cross-linking for 0.5-12 hours, and then immerse the materials in 0.1-0.5 mol/L Ca(NO 3 ) In the 2 solution for 4~24h, replace the Ca(NO 3 ) 2 solution every 12h, take it out and rinse it gently with deionized water 3 times;
(4)胶原基材料的仿生矿化:将步骤(3)所得胶原基材料在37℃下浸没于1~10倍的SBF溶液中,并添加微量聚丙烯酸(PAA)溶液,使其浓度为20~60μg/ml,仿生矿化12~336h,每12h更换一次1~10倍的SBF溶液,取出用去离子水轻轻冲洗3次,经冷冻干燥、灭菌处理,即得胶原基复合口腔修复膜材料。 (4) Biomimetic mineralization of collagen-based materials: the collagen-based materials obtained in step (3) were immersed in 1-10 times the SBF solution at 37 °C, and a small amount of polyacrylic acid (PAA) solution was added to make the concentration 20 ~60μg/ml, biomimetic mineralization for 12~336h, replace 1~10 times of SBF solution every 12h, take it out and rinse gently with deionized water for 3 times, freeze-dry and sterilize to get collagen-based composite oral restoration membrane material.
所述的胶原基复合口腔修复膜材料及其制备方法,其特征在于,所述氧化剂为高碘酸钠或高氯酸钠中的一种或两种。 The collagen-based composite oral repair membrane material and its preparation method are characterized in that the oxidizing agent is one or both of sodium periodate and sodium perchlorate.
所述的胶原基复合口腔修复膜材料及其制备方法,其特征在于,所述缓冲液为pH值为7~7.5的磷酸盐缓冲液。 The collagen-based composite oral repair membrane material and its preparation method are characterized in that the buffer is a phosphate buffer with a pH value of 7-7.5.
所述的胶原基复合口腔修复膜材料及其制备方法,其特征在于,所述氧化羧甲基壳聚糖与Ⅰ型胶原的质量比为1~3:10。 The collagen-based composite oral repair membrane material and its preparation method are characterized in that the mass ratio of oxidized carboxymethyl chitosan to type I collagen is 1-3:10.
所述的胶原基复合口腔修复膜材料及其制备方法,其特征在于,所述交联剂为1-乙基-3-(3-二甲基胺丙基)-碳化二亚胺、N-羟基琥珀酰亚胺、京尼平、原花青素、戊二醛的任一种或两种。 The collagen-based composite oral repair film material and its preparation method are characterized in that the crosslinking agent is 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide, N- Either or both of hydroxysuccinimide, genipin, proanthocyanidins, and glutaraldehyde.
所述的胶原基复合口腔修复膜材料及其制备方法,其特征在于,所述胶原基材料与1~10倍SBF溶液的质量比为1:25~300。 The collagen-based composite oral repair membrane material and its preparation method are characterized in that the mass ratio of the collagen-based material to 1-10 times the SBF solution is 1:25-300.
由上述方法制备得到的胶原基复合口腔修复膜材料,其关键性能指标应符合以下要求: The key performance indicators of the collagen-based composite dental repair membrane material prepared by the above method should meet the following requirements:
外观:白色或微黄色膜状物,柔软,无肉眼可见杂质; Appearance: white or yellowish film, soft, without visible impurities;
重金属含量:≤10μg/ml; Heavy metal content: ≤10μg/ml;
细胞毒性:细胞毒性反应不大于1级; Cytotoxicity: the cytotoxic reaction is not greater than grade 1;
无菌试验:无菌; Sterility test: sterile;
致敏试验:无迟发性的超敏反应; Sensitization test: no delayed hypersensitivity reaction;
皮内反应试验:原发性刺激指数PII<0.4。 Intradermal test: primary irritation index PII<0.4.
与现有技术相比,本发明具有如下优点: Compared with prior art, the present invention has following advantage:
(1)本发明采用热驱动促进胶原自组装,在制备方法上模拟人体天然牙的形成过程,使胶原基复合材料具有良好的生物相容性; (1) The present invention uses thermal drive to promote collagen self-assembly, and simulates the formation process of human natural teeth in the preparation method, so that the collagen-based composite material has good biocompatibility;
(2)本发明采用氧化羧甲基壳聚糖对Ⅰ型胶原进行复合改性,氧化羧甲基壳聚糖与Ⅰ型胶原产生原位交联,能显著提高Ⅰ型胶原的稳定性以及可降解吸收性,同时羧甲基基团的存在有利于后期Ca2+离子的沉积。根据协同理论,本发明的胶原基复合膜材料也具有抗菌抑菌性、抗氧化性、促进伤口愈合等优点; (2) The present invention uses oxidized carboxymethyl chitosan to compound and modify type I collagen, and oxidized carboxymethyl chitosan and type I collagen produce in-situ cross-linking, which can significantly improve the stability of type I collagen and can Degradation of absorbency, while the presence of carboxymethyl groups is conducive to the deposition of Ca 2+ ions in the later stage. According to the theory of synergy, the collagen-based composite membrane material of the present invention also has the advantages of antibacterial and antibacterial properties, anti-oxidation properties, and promotion of wound healing;
(3)本发明采用预处理与人体生理体液仿生矿化相结合的方法,在胶原基材料上引入了具有生物活性的羟基磷灰石,与人体天然牙的成分与结构相似,有利于口腔修复; (3) The present invention adopts the method of combining pretreatment with biomimetic mineralization of human physiological body fluids, and introduces biologically active hydroxyapatite into the collagen-based material, which is similar to the composition and structure of human natural teeth, which is beneficial to oral restoration ;
(4)本发明在仿生矿化过程中添加微量聚丙烯酸(PAA)溶液,有利于在胶原基材料上构建从纳米到微米的多级有序结构,可进一步提高膜材料的生物相容性。 (4) The present invention adds a small amount of polyacrylic acid (PAA) solution in the biomimetic mineralization process, which is beneficial to construct a multi-level ordered structure from nanometer to micrometer on the collagen-based material, and can further improve the biocompatibility of the membrane material.
具体实施方式 detailed description
下面通过实施对本发明进行具体的描述,有必要在此指出的是,本实施例只用于对本发明进行进一步说明,而不能理解为对本发明保护范围的限制,该领域的技术熟练人员可以根据上述发明的内容做出一些非本质的改进和调整。 The present invention will be specifically described below by implementing it. It is necessary to point out that this embodiment is only used to further illustrate the present invention, and can not be interpreted as limiting the protection scope of the present invention. Those skilled in the art can according to the above-mentioned The content of the invention makes some non-essential improvements and adjustments.
实施例1Example 1
(1)氧化羧甲基壳聚糖的制备:将60重量份的去离子水加入到不锈钢反应釜中,然后将羧甲基壳聚糖与氧化剂以1:1的质量比加入,并使之溶解完全。接着,在20℃下避光搅拌反应48h,再加入5重量份的氯化钠与600体积份的无水乙醇,静置,将底部液体以15000r/min离心20min,最后在去离子水中透析5d,冷冻干燥即得氧化羧甲基壳聚糖; (1) Preparation of oxidized carboxymethyl chitosan: Add 60 parts by weight of deionized water into a stainless steel reactor, then add carboxymethyl chitosan and oxidant at a mass ratio of 1:1, and make it Dissolve completely. Next, stir and react in the dark at 20°C for 48 hours, then add 5 parts by weight of sodium chloride and 600 parts by volume of absolute ethanol, let it stand still, centrifuge the bottom liquid at 15,000 r/min for 20 minutes, and finally dialyze it in deionized water for 5 days , freeze-drying to obtain oxidized carboxymethyl chitosan;
(2)热驱动Ⅰ型胶原自组装:将Ⅰ型胶原溶解在缓冲液中,使得Ⅰ型胶原浓度为3mg/ml。将搅拌均匀的Ⅰ型胶原溶液在37℃下孵化20h后,加入氧化羧甲基壳聚糖搅拌5h,再在37℃下继续孵化20h,最后将产物冷冻干燥备用; (2) Heat-driven self-assembly of type I collagen: Dissolve type I collagen in the buffer so that the concentration of type I collagen is 3 mg/ml. After incubating the well-stirred type I collagen solution at 37°C for 20 hours, add oxidized carboxymethyl chitosan and stir for 5 hours, then continue to incubate at 37°C for 20 hours, and finally freeze-dry the product for later use;
(3)胶原基材料的预处理:将步骤(2)所得胶原基材料浸入1-乙基-3-(3-二甲基胺丙基)-碳化二亚胺/N-羟基琥珀酰亚胺溶液中交联4h,然后将材料在37℃下浸没于0.2mol/L的Ca(NO3)2溶液中6h,取出后用去离子水轻轻冲洗3次; (3) Pretreatment of collagen-based materials: immerse the collagen-based materials obtained in step (2) in 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide Crosslink in the solution for 4 hours, then immerse the material in 0.2mol/L Ca(NO 3 ) 2 solution at 37°C for 6 hours, take it out and rinse it gently with deionized water for 3 times;
(4)胶原基材料的仿生矿化:将步骤(3)所得胶原基材料在37℃下浸没于5倍的SBF溶液中,并添加微量聚丙烯酸(PAA)溶液,使其浓度为30μg/ml,仿生矿化168h,每12h更换一次5倍的SBF溶液,取出用去离子水轻轻冲洗3次,经冷冻干燥、灭菌处理,即得胶原基复合口腔修复膜材料。 (4) Biomimetic mineralization of collagen-based materials: The collagen-based materials obtained in step (3) were immersed in 5 times the SBF solution at 37°C, and a small amount of polyacrylic acid (PAA) solution was added to make the concentration 30 μg/ml , Biomimetic mineralization for 168 hours, replace the 5 times SBF solution every 12 hours, take it out and rinse it gently with deionized water for 3 times, freeze-dry and sterilize to obtain the collagen-based composite oral repair membrane material.
实施例2Example 2
(1)氧化羧甲基壳聚糖的制备:将80重量份的去离子水加入到不锈钢反应釜中,然后将羧甲基壳聚糖与氧化剂以1:0.5的质量比加入,并使之溶解完全。接着,在10℃下避光搅拌反应24h,再加入10重量份的氯化钠与500体积份的无水乙醇,静置,将底部液体以10000r/min离心20min,最后在去离子水中透析5d,冷冻干燥即得氧化羧甲基壳聚糖; (1) Preparation of oxidized carboxymethyl chitosan: Add 80 parts by weight of deionized water into a stainless steel reactor, then add carboxymethyl chitosan and oxidant at a mass ratio of 1:0.5, and make it Dissolve completely. Next, stir and react in the dark at 10°C for 24 hours, then add 10 parts by weight of sodium chloride and 500 parts by volume of absolute ethanol, let it stand still, centrifuge the bottom liquid at 10,000 r/min for 20 minutes, and finally dialyze it in deionized water for 5 days , freeze-drying to obtain oxidized carboxymethyl chitosan;
(2)热驱动Ⅰ型胶原自组装:将Ⅰ型胶原溶解在缓冲液中,使得Ⅰ型胶原浓度为5mg/ml。将搅拌均匀的Ⅰ型胶原溶液在37℃下孵化20h后,加入氧化羧甲基壳聚糖搅拌6h,再在37℃下继续孵化20h,最后将产物冷冻干燥备用; (2) Heat-driven self-assembly of type I collagen: Dissolve type I collagen in buffer so that the concentration of type I collagen is 5 mg/ml. After incubating the well-stirred type I collagen solution at 37°C for 20 hours, add oxidized carboxymethyl chitosan and stir for 6 hours, then continue to incubate at 37°C for 20 hours, and finally freeze-dry the product for later use;
(3)胶原基材料的预处理:将步骤(2)所得胶原基材料浸入戊二醛溶液中交联4h,然后将材料在37℃下浸没于0.1mol/L的Ca(NO3)2溶液中16h,每12h更换一次Ca(NO3)2溶液,取出后用去离子水轻轻冲洗3次; (3) Pretreatment of collagen-based materials: immerse the collagen-based materials obtained in step (2) in glutaraldehyde solution for cross-linking for 4 hours, and then immerse the materials in 0.1mol/L Ca(NO 3 ) 2 solution at 37°C For 16 hours, replace the Ca(NO 3 ) 2 solution every 12 hours, take it out and rinse it gently with deionized water for 3 times;
(4)胶原基材料的仿生矿化:将步骤(3)所得胶原基材料在37℃下浸没于1.5倍的SBF溶液中,并添加微量聚丙烯酸(PAA)溶液,使其浓度为50μg/ml,仿生矿化240h,每12h更换一次1.5倍的SBF溶液,取出用去离子水轻轻冲洗3次,经冷冻干燥、灭菌处理,即得胶原基复合口腔修复膜材料。 (4) Biomimetic mineralization of collagen-based materials: the collagen-based materials obtained in step (3) were immersed in 1.5 times the SBF solution at 37°C, and a small amount of polyacrylic acid (PAA) solution was added to make the concentration 50 μg/ml , Biomimetic mineralization for 240 hours, replace 1.5 times of SBF solution every 12 hours, take it out and rinse it gently with deionized water for 3 times, freeze-dry and sterilize to obtain the collagen-based composite oral repair membrane material.
实施例3Example 3
(1)氧化羧甲基壳聚糖的制备:将50重量份的去离子水加入到不锈钢反应釜中,然后将羧甲基壳聚糖与氧化剂以1:1.5的质量比加入,并使之溶解完全。接着,在4℃下避光搅拌反应12h,再加入15重量份的氯化钠与700体积份的无水乙醇,静置,将底部液体以15000r/min离心15min,最后在去离子水中透析5d,冷冻干燥即得氧化羧甲基壳聚糖; (1) Preparation of oxidized carboxymethyl chitosan: Add 50 parts by weight of deionized water into a stainless steel reactor, then add carboxymethyl chitosan and oxidant at a mass ratio of 1:1.5, and make it Dissolve completely. Next, stir and react at 4°C for 12 hours in the dark, then add 15 parts by weight of sodium chloride and 700 parts by volume of absolute ethanol, let it stand, centrifuge the bottom liquid at 15,000 r/min for 15 minutes, and finally dialyze it in deionized water for 5 days , freeze-drying to obtain oxidized carboxymethyl chitosan;
(2)热驱动Ⅰ型胶原自组装:将Ⅰ型胶原溶解在缓冲液中,使得Ⅰ型胶原浓度为1mg/ml。将搅拌均匀的Ⅰ型胶原溶液在37℃下孵化20h后,加入氧化羧甲基壳聚糖搅拌5h,再在37℃下继续孵化20h,最后将产物冷冻干燥备用; (2) Heat-driven type I collagen self-assembly: Dissolve type I collagen in the buffer so that the type I collagen concentration is 1 mg/ml. After incubating the well-stirred type I collagen solution at 37°C for 20 hours, add oxidized carboxymethyl chitosan and stir for 5 hours, then continue to incubate at 37°C for 20 hours, and finally freeze-dry the product for later use;
(3)胶原基材料的预处理:将步骤(2)所得胶原基材料浸入京尼平溶液中交联6h,然后将材料在37℃下浸没于0.1mol/L的Ca(NO3)2溶液中10h,取出后用去离子水轻轻冲洗3次; (3) Pretreatment of collagen-based materials: immerse the collagen-based materials obtained in step (2) in genipin solution for cross-linking for 6 hours, and then immerse the materials in 0.1mol/L Ca(NO 3 ) 2 solution at 37°C 10h, after taking it out, rinse it gently with deionized water for 3 times;
(4)胶原基材料的仿生矿化:将步骤(3)所得胶原基材料在37℃下浸没于2倍的SBF溶液中,并添加微量聚丙烯酸(PAA)溶液,使其浓度为40μg/ml,仿生矿化288h,每12h更换一次2倍的SBF溶液,取出用去离子水轻轻冲洗3次,经冷冻干燥、灭菌处理,即得胶原基复合口腔修复膜材料。 (4) Biomimetic mineralization of collagen-based materials: immerse the collagen-based materials obtained in step (3) in 2 times the SBF solution at 37 °C, and add a small amount of polyacrylic acid (PAA) solution to make the concentration 40 μg/ml , Biomimetic mineralization for 288 hours, replace 2 times the SBF solution every 12 hours, take it out and rinse it gently with deionized water for 3 times, freeze-dry and sterilize to obtain the collagen-based composite oral repair membrane material.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610130834.3A CN105688288B (en) | 2016-03-09 | 2016-03-09 | Compound oral restoration membrane material of collagen-based and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610130834.3A CN105688288B (en) | 2016-03-09 | 2016-03-09 | Compound oral restoration membrane material of collagen-based and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105688288A true CN105688288A (en) | 2016-06-22 |
CN105688288B CN105688288B (en) | 2019-03-05 |
Family
ID=56221020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610130834.3A Active CN105688288B (en) | 2016-03-09 | 2016-03-09 | Compound oral restoration membrane material of collagen-based and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105688288B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106237386A (en) * | 2016-08-29 | 2016-12-21 | 东华大学 | A kind of natural fibroin base macropore support for bone defect healing and preparation method thereof |
CN112206359A (en) * | 2020-08-31 | 2021-01-12 | 中国人民解放军空军军医大学 | Self-mineralized collagen membrane, preparation method and application |
CN112267169A (en) * | 2020-10-22 | 2021-01-26 | 湖南翰坤实业有限公司 | Degradable toothbrush main material with self-cleaning function |
CN114425103A (en) * | 2022-04-06 | 2022-05-03 | 中国科学院苏州纳米技术与纳米仿生研究所 | Bionic biogel and preparation method and application thereof |
CN115137882A (en) * | 2022-08-03 | 2022-10-04 | 四川大学 | Method for modularly assembling collagen membrane by utilizing LB (Luria Brouss) technology |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006068972A2 (en) * | 2004-12-21 | 2006-06-29 | Ethicon, Inc. | Tissue engineering devices for the repair and regeneration of tissue |
CN104013995A (en) * | 2014-06-26 | 2014-09-03 | 四川大学 | Oxidation chitosan graft modified porcine dermal collagen micro-nano fiber membrane and preparation method thereof |
CN104922732A (en) * | 2014-03-19 | 2015-09-23 | 北京天新福医疗器材有限公司 | Preparation method of oral biofilm |
-
2016
- 2016-03-09 CN CN201610130834.3A patent/CN105688288B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006068972A2 (en) * | 2004-12-21 | 2006-06-29 | Ethicon, Inc. | Tissue engineering devices for the repair and regeneration of tissue |
CN104922732A (en) * | 2014-03-19 | 2015-09-23 | 北京天新福医疗器材有限公司 | Preparation method of oral biofilm |
CN104013995A (en) * | 2014-06-26 | 2014-09-03 | 四川大学 | Oxidation chitosan graft modified porcine dermal collagen micro-nano fiber membrane and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
XINHUA LIU等: ""Feasibility study of the natural derived chitosan dialdehyde forchemical modification of collagen"", 《INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES》 * |
叶勇等: ""胶原基膜材料在牙组织引导中的应用"", 《中国皮革》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106237386A (en) * | 2016-08-29 | 2016-12-21 | 东华大学 | A kind of natural fibroin base macropore support for bone defect healing and preparation method thereof |
CN112206359A (en) * | 2020-08-31 | 2021-01-12 | 中国人民解放军空军军医大学 | Self-mineralized collagen membrane, preparation method and application |
CN112267169A (en) * | 2020-10-22 | 2021-01-26 | 湖南翰坤实业有限公司 | Degradable toothbrush main material with self-cleaning function |
CN114425103A (en) * | 2022-04-06 | 2022-05-03 | 中国科学院苏州纳米技术与纳米仿生研究所 | Bionic biogel and preparation method and application thereof |
CN115137882A (en) * | 2022-08-03 | 2022-10-04 | 四川大学 | Method for modularly assembling collagen membrane by utilizing LB (Luria Brouss) technology |
CN115137882B (en) * | 2022-08-03 | 2023-07-21 | 四川大学 | A Method for Modularly Assembling Collagen Membranes Using LB Technology |
Also Published As
Publication number | Publication date |
---|---|
CN105688288B (en) | 2019-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yuan et al. | An M2 macrophage-polarized anti-inflammatory hydrogel combined with mild heat stimulation for regulating chronic inflammation and impaired angiogenesis of diabetic wounds | |
CN105688288A (en) | Collagen based composite dental restoration membrane material and preparation method thereof | |
Kang et al. | Injectable intrinsic photothermal hydrogel bioadhesive with on‐demand removability for wound closure and mrsa‐infected wound healing | |
CN102380128B (en) | Hydroxyapatite, sodium hyaluronate and konjac glucomannan composite material and preparation method thereof | |
CN104013995B (en) | Oxidation chitosan graft modification pig dermis collagen micro-nano fiber film and preparation method thereof | |
Wang et al. | Biomimetic mineralized hydroxyapatite nanofiber-incorporated methacrylated gelatin hydrogel with improved mechanical and osteoinductive performances for bone regeneration | |
Han et al. | A multifunctional mussel-inspired hydrogel with antioxidant, electrical conductivity and photothermal activity loaded with mupirocin for burn healing | |
CN108192427B (en) | Dopamine-hyaluronic acid coating material, preparation method and its application in promoting specific adhesion of dental pulp stem cells to dentin | |
CN108744055B (en) | Silk fibroin bone cement biological adhesive and preparation method thereof | |
CN104888273B (en) | A kind of double-layer composite endocranium and preparation method thereof | |
CN114452436B (en) | Collagen-based injectable self-repairing hydrogel and preparation method thereof | |
CN106693050B (en) | A preparation method of composite scaffold material based on collagen and collagen fibers | |
CN105457107B (en) | A kind of bifunctional layer oral restoration film and preparation method thereof | |
CN107469151A (en) | A kind of alveolar bone repairing material and its preparation method and application | |
CN103386150B (en) | Preparation method and application of glucomannan/chitosan composite membrane for conducting tissue regeneration | |
CN116747348A (en) | 3D printing ink, preparation method thereof and printing method | |
CN108295029A (en) | A kind of injection Multifunctional composite water gel and preparation method thereof | |
Wang et al. | Genipin crosslinked quaternary ammonium chitosan hydrogels for wound dressings | |
CN107823717B (en) | A kind of preparation method of anti-calcification biological patch | |
CN108939132A (en) | A kind of high bioactivity hyaluronic acid medical film and preparation method thereof based on the modification of low immunogenicity collagen | |
CN109908394A (en) | Degradable medical antibacterial anti-leakage protective film and preparation method thereof | |
CN1319437A (en) | Process for preparation of chitosan-gelatin network/calcium phosphate porous compound support frame material | |
CN105686956B (en) | Pig dermis matrix-oxidated carboxymethyl chitosan-hydroxyapatite dental prosthetic material and preparation method thereof | |
CN110721348A (en) | A kind of natural silk reinforced hydroxyapatite/chitosan composite film and preparation method | |
CN117771430A (en) | Double-crosslinked hydrogel and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |